Maca Lepidium meyenii Walp.
Also called: Peruvian ginseng (common name; maca belongs to the mustard family), Lepidium peruvianum (synonym)
Maca is a mustard-family plant grown at high altitude in the Peruvian Andes. Its turnip-like underground part (hypocotyl and root) is eaten as a food and used traditionally for energy and fertility; supplements contain raw or gelatinized powder or extracts.
- Category
- Botanical
- Part used
- Hypocotyl and root (dried, raw or gelatinized powder; extracts)
- Strongest evidence
- C Limited
- Native range
- Native from southern Peru to northwestern Argentina (POWO: "S. Peru to NW. Argentina")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. A 2022 systematic review (Front Pharmacol) found 5 placebo-controlled RCTs of maca alone (gelatinized powder or extract) on semen quality; earlier reviews found 4 RCTs each for sexual function (2010) and menopausal symptoms (2011). No review pooling 5 or more was found. [5]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CHormones and reproduction3 topics
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Sexual function and desire | C | A 2010 systematic review found four small randomized trials (three positive, one negative) and judged the evidence limited; trial numbers, sample sizes and quality were too low for firm conclusions. [3] |
| Menopausal symptoms | C | A 2011 systematic review of four randomized trials in peri- and postmenopausal women found favorable effects on symptom scores but rated the evidence limited because of few, small and lower-quality trials. [4] |
| Semen quality | C | A 2022 meta-analysis of five randomized trials found mixed effects and no significant increase in sperm concentration versus placebo in men with infertility. [5] |
| Overall clinical evidence | C | LiverTox states that human studies have had conflicting results and none of maca's promoted effects has been proven in prospective, rigorously controlled trials. [1] |
Main constituents: Principal components are carbohydrates and protein; secondary components include macaridine, macaenes, macamides, maca alkaloids, sterols and glucosinolates [1]; Glucosinolates, mostly benzylglucosinolate; macamides are normally not present in fresh plants but are introduced during traditional drying; composition differences among red, yellow, purple and black phenotypes may be associated with different biological effects [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Health Canada monograph (adults): 2 to 3.5 g dried root/hypocotyl daily for mood balance during menopause; 3 to 3.5 g daily for emotional aspects of sexual health; not to exceed 3 g daily as an antioxidant. [6]
- LiverTox describes recommended amounts varying widely, 500 to 3,000 mg daily depending on the preparation; one randomized trial gave 3 g of red or black maca daily for 12 weeks to 175 adults. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E: unlikely cause of clinically apparent liver injury.
Details and sources - Pregnancy and breastfeedingHealth Canada: ask a health care practitioner before use if pregnant or breastfeeding.
2 statements in the profile.
Details and sources - Interactions with medicines3 listed
Blood thinners; Losartan; Organic nitrates (e.g., nitroglycerin), via adulterated products
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Canada (Health Canada NNHPD monograph, September 27, 2024), adults, dried root/hypocotyl per day: antioxidant, not to exceed 3 g …
Details and sources
- Side effects are uncommon and mild, mostly gastrointestinal symptoms and headaches. Liver: LiverTox likelihood score E (unlikely cause of clinically apparent liver injury). [1]
- Reported effects include altered menstrual cycles, moodiness, cramps, gastritis and insomnia; one case report described prolonged intermenstrual bleeding and elevated testosterone in a woman taking about one teaspoon of powder daily. [2]
- Health Canada requires a label caution to consult a practitioner if pregnant or breastfeeding; for products providing 0.6 g or more daily, also with a blood pressure condition or when taking blood thinners; and, for mood and sexual-health uses, with anxiety or depression. [6]
- Some products sold as maca have been spiked with undeclared PDE5-inhibitor drug analogues such as thiosildenafil; PDE5 inhibitors are contraindicated with organic nitrates such as nitroglycerin because combined use can cause a significant drop in blood pressure. [7]
Interactions
| With | What happens |
|---|---|
| Blood thinners | For products providing 0.6 g or more daily, Health Canada requires a label caution to ask a health care practitioner before use if taking blood thinners. [6] |
| Losartan | Maca enhanced losartan's blood-pressure-lowering effect in hypertensive rats; clinical relevance is undetermined. [2] |
| Testosterone immunoassays (lab test) | Maca may interfere with testosterone immunoassays. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- BAPP (2018): reported adulteration includes substitution with wheat flour or yam, extracts on corn starch sold as root powder, and spiking with synthetic PDE5 inhibitors; 1 of 31 US root powders was clearly adulterated and 8 to 10 were suspected. [7]
- No compendial methods exist for maca; published methods include HPLC-UV for macamides and macaenes, DNA barcoding, and TLC with LC-MS/MS for drug adulterants. [7]
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [9]
- Canada: Health Canada's Maca monograph (September 27, 2024) allows claims for antioxidants, healthy mood balance during menopause, and emotional aspects of sexual health for adults. [6]
- Peru allows maca to be exported only as dried maca, toasted maca flour or gelatinized maca flour, not in a fresh raw state. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming maca (Lepidium meyenii) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of maca (Lepidium meyenii) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P4]
Liver (NIH LiverTox)
- LiverTox likelihood score E: unlikely cause of clinically apparent liver injury. No convincing reports link maca to serum enzyme elevations or acute liver injury, although its use as an herbal supplement has been limited (chapter updated 2019-04-10). [P5]
Interactions with medicines
- Blood thinners: Health Canada requires a label caution (products providing 0.6 g or more dried root/hypocotyl daily) to ask a health care practitioner before use if taking blood thinners. [P6]
- Losartan: Enhanced losartan's blood-pressure-lowering effect in hypertensive rats; clinical relevance undetermined. [P2]
- Organic nitrates (e.g., nitroglycerin), via adulterated products: Maca supplements adulterated with PDE5 inhibitors pose a risk because PDE5 drugs are contraindicated with organic nitrates; concomitant use can cause a significant decrease in blood pressure. [P1]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- BAPP bulletin 'Adulteration of maca (Lepidium meyenii)' (September 2018): reports of substitution with wheat flour or yam, a maca extract on corn starch sold as root powder (no maca DNA detected), spiking with PDE5 inhibitors (thiosildenafil; the sildenafil analogue desethylcarbodenafil), potential spiking of extracts with synthetic macamides, and Chinese-grown maca sold as Peruvian. [P1]
- Frequency: of 31 US maca root powders tested by 1H NMR, one was clearly adulterated and 8 to 10 were suspected; in another study, 8 of 9 multicomponent formulas had little or no detectable marker macamide and one contained thiosildenafil. [P1]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P7]
- DNA barcoding (ITS sequence) or FTIR/TLC/GC-MS for species identity — BAPP reports that DNA barcoding with the ITS sequence could distinguish maca from turnips, radishes, potatoes, corn and 15 Lepidium species; there are no compendial methods for maca. [P1]
- Screening for PDE5 inhibitors and analogues (TLC, HPLC-DAD, GC-MS, LC-MS/MS) — Maca supplements have been found spiked with thiosildenafil and desethylcarbodenafil. [P1]
- Macamide and macaene assay (HPLC-UV or HPLC-UV-MS/MS) — BAPP describes validated HPLC methods for these markers, but notes they were not evaluated for detecting adulteration and that macamides can be synthesized cheaply for spiking. [P1]
Supply and conservation
- Cultivated mainly in the Junin, Pasco and Huancayo areas of central Peru at about 3,500 to 4,500 m; suppliers estimated over 70% of Peru's maca is grown in Junin. Peru allows export only as dried maca, toasted flour or gelatinized flour. [P1]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Canada (Health Canada NNHPD monograph, September 27, 2024), adults, dried root/hypocotyl per day: antioxidant, not to exceed 3 g; mood balance during menopause, 2 to 3.5 g; emotional aspects of sexual health, 3 to 3.5 g. Consult a practitioner for use beyond 3 months (0.6 to 3 g/day) or beyond 6 weeks (more than 3 g/day). [P6]
Sources for this profile
- Stewart J, Chioffi B. Adulteration of maca (Lepidium meyenii). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; September 2018, 2018-09. umb.herbalgram.org
- Memorial Sloan Kettering Cancer Center. About Herbs: Maca (last updated June 7, 2023), 2023-06-07. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- NIH LiverTox (NIDDK). Maca (Last Update: 2019-04-10), 2019-04-10. ncbi.nlm.nih.gov
- Health Canada, Natural and Non-prescription Health Products Directorate. Monograph: Maca - Lepidium meyenii (dated September 27, 2024), 2024-09-27. webprod.hc-sc.gc.ca
- eCFR. 21 CFR 111.75 (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH LiverTox (NIDDK). Maca (Last Update: 2019-04-10), 2019-04-10. ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Maca (last updated June 7, 2023), 2023-06-07. mskcc.org
- Shin BC, et al. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med 2010;10:44 (PMID 20691074), 2010-08-06. pubmed.ncbi.nlm.nih.gov
- Lee MS, et al. Maca (Lepidium meyenii) for treatment of menopausal symptoms: a systematic review. Maturitas 2011;70(3):227-33 (PMID 21840656), 2011-11. pubmed.ncbi.nlm.nih.gov
- Lee HW, et al. Maca (Lepidium meyenii Walp.) on semen quality parameters: a systematic review and meta-analysis. Front Pharmacol 2022;13:934740 (PMID 36110519), 2022-08-30. pubmed.ncbi.nlm.nih.gov
- Health Canada, Natural and Non-prescription Health Products Directorate. Monograph: Maca - Lepidium meyenii (dated September 27, 2024), 2024-09-27. webprod.hc-sc.gc.ca
- Stewart J, Chioffi B. Adulteration of maca (Lepidium meyenii). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; September 2018, 2018-09. umb.herbalgram.org
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Lepidium meyenii Walp. (accessed 2026-10-29); synonym Lepidium peruvianum G.Chacón per WCVP (GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, 2026-06-04). powo.science.kew.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.